Alterations in the insulin-like growth factor system during treatment with diethylstilboestrol in patients with metastatic breast cancer

Alterations in the insulin-like growth factor (IGF)-system were evaluated in 16 patients treated with diethylstilboestrol 5 mg 3 times daily. Fasting blood samples were obtained before treatment and after 2 weeks, 1 month and/or 2–3 months on therapy. Insulin-like growth factor (IGF)-I, IGF-II, free...

Descripción completa

Detalles Bibliográficos
Autores principales: Helle, S I, Geisler, J, Anker, G B, Leirvaag, B, Holly, J M P, Lønning, P E
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364048/
https://www.ncbi.nlm.nih.gov/pubmed/11461068
http://dx.doi.org/10.1054/bjoc.2001.1871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364048/
https://www.ncbi.nlm.nih.gov/pubmed/11461068
http://dx.doi.org/10.1054/bjoc.2001.1871

Ejemplares similares